Adverse Effects in Hospice Patients with Chronic Kidney Disease Receiving Hydromorphone

Gobi Paramanandam, Eric Prommer, Dawn C. Schwenke

Journal of Palliative Medicine · 2011 · 57 citations · 8 references

Abstract

Parenteral hydromorphone has few neuroexcitatory symptoms until H3G accumulates past a neurotoxic threshold, such as might occur with increasing dose or duration, which, when exceeded, causes neuroexcitatory symptoms to manifest.

References

8